Key result
Controlling blood pressure to < 130/80 mmHg is a crucial therapeutic target in diabetic kidney disease, requiring appropriate measurement and treatments.
This review emphasizes the critical role of accurate blood pressure measurement and targeting < 130/80 mmHg to manage cardiovascular risk in patients with diabetic kidney disease.
Reinforces <130/80 mmHg target with measurement guidance in diabetic kidney disease; leaves open need for updated RCTs to refine thresholds.
In Brief Diabetes is associated with markedly increased cardiovascular risk, a risk compounded with imposition of chronic kidney disease (CKD). More than 80% of people with diabetes and CKD have hypertension, and many have an obliterated nocturnal blood pressure “dip,” the normal physiological drop in blood pressure during sleep. Appropriate blood pressure measurement is the Achilles heel of hypertension management, especially in diabetic kidney disease (DKD). This review elaborates on the evidence regarding one of the most important therapeutic targets in DKD, namely, control of blood pressure to < 130/80 mmHg, and provides detailed information about appropriate blood pressure measurement and treatments to best achieve that target.
No takes yet. Share an insight, caveat, or question.
Susan Steigerwalt (2008) conducted a review in Diabetic kidney disease with hypertension. Control of blood pressure to < 130/80 mmHg was evaluated. Controlling blood pressure to < 130/80 mmHg is a crucial therapeutic target in diabetic kidney disease, requiring appropriate measurement and treatments.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: